The SMi Group will organize its 3th Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 13th-14th May 2019.
BSP Pharmaceuticals S.p.A. is proud to announce Its sponsorship to this event for the first time. The HPAPI global market has developed rapidly in the past year and is continuing to expand into the future, with over a quarter of drugs in development worldwide being classified as highly potent. As a result, there is a growing demand for both pharmaceutical and contracted manufacturers to adapt to the evolving HPAPI landscape.
This conference will explore current market trends, challenges of correctly assessing hazard, the use of innovative containment solutions to minimize risk and advanced manufacturing processes. In addition, the conference aims to guide attendees through novel regulatory updates for each stage of HPAPI development.
